Company: AEMD
Filing Date: 2025-06-26
Form Type: 10-K
Source: 0001683168-25-004780
Chunk: 574

Company: AETHLON MEDICAL INC
Filing Date: 2025-06-26
Form: 10-K
Item: Item 2
Chunk 574
---
, then monthly over the following 36 months, subject to Mr. Cipriani’s continued service with the Company.

    (6)
    This option is subject to vesting at a rate of 25% on the one year anniversary of the grant date of February 10, 2022, then monthly over the following 36 months, subject to Mr. Cipriani’s continued service with the Company.

 69 

Director Compensation for 2025 Fiscal Year

The following director compensation
disclosure reflects all compensation awarded to, earned by or paid to our then non-employee directors for the fiscal year ended March
31, 2025.

    Fees Earned or Paid in Cash ($)  
    Stock Awards ($)(1)  
    Total ($) 
  
    Edward G. Broenniman (2) 
     97,500  
     50,000  
     147,500 
  
    Nicolas Gikakis (3) 
     48,750  
     50,000  
     98,750 
  
    Angela Rossetti (4) 
     63,000  
     50,000  
     113,000 
  
    Chetan S. Shah, M.D. (5) 
     63,750  
     50,000  
     113,750 

    (1)
    In accordance with SEC rules, this column reflects the aggregate grant date fair value of the awards computed in accordance with Financial Accounting Standard Board Accounting Standards Codification Topic 718 for stock-based compensation transactions. Assumptions used in the calculation of these amounts are included in our consolidated financial statements in this Annual Report. These amounts do not reflect the actual economic value that will be realized by our directors upon the vesting, exercise, or the sale of the shares of common stock underlying such awards.

    (2)
    In the fiscal year ended March 31, 2025, Mr. Broenniman earned $30,000 in cash compensation for his services to us as non-executive Chairman and $67,500 related to his roles as a member of our Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee and as the chair of our Audit Committee, for an aggregate amount of $97,500. Mr. Broenniman also received restricted stock units, or RSUs, valued at $50,000 for his ongoing service as a Board member pursuant to our Amended